| NCT ID | NCT07067827 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CHU de Quebec-Universite Laval |
| Condition | Osteoporosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 58 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 58 participants in total. It began in 2026-04-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Osteoporosis is a multifactorial disease in which genetic predispositions play a key role in its development. A better understanding of family history and clinical manifestations among first- and second-degree relatives can help improve early detection and personalized care for at-risk patients. To this end, we will test a self-administered questionnaire previously developed by our research team. This questionnaire includes the main manifestations associated with rare genetic bone diseases such as osteogenesis imperfecta, hypophosphatasia, and osteopetrosis.
Eligibility Criteria
Inclusion Criteria: * Adult over 18 * Followed by the rheumatology or endocrinology clinics at the CHUL (CHU de Quebec-Universite Laval) * Suffer from osteoporosis * Have internet access Exclusion Criteria: * Unfit, unable to consent, unable to answer a questionnaire, unknown family history (e.g. adopted person)
Contact & Investigator
Laetitia Michou, MD PhD
PRINCIPAL INVESTIGATOR
CHU de Quebec-Universite Laval
Frequently Asked Questions
Who can join the NCT07067827 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07067827 currently recruiting?
Yes, NCT07067827 is actively recruiting participants. Contact the research team at laetitia.michou@crchudequebec.ulaval.ca for enrollment information.
Where is the NCT07067827 trial being conducted?
This trial is being conducted at Québec, Canada.
Who is sponsoring the NCT07067827 clinical trial?
NCT07067827 is sponsored by CHU de Quebec-Universite Laval. The principal investigator is Laetitia Michou, MD PhD at CHU de Quebec-Universite Laval. The trial plans to enroll 58 participants.